162 related articles for article (PubMed ID: 15164988)
1. Toxicity and cerebrospinal fluid levels of carboplatin chronically infused into the brainstem of a primate.
Strege RJ; Liu YJ; Kiely A; Johnson RM; Gillis EM; Storm P; Carson BS; Jallo GI; Guarnieri M
J Neurooncol; 2004 May; 67(3):327-34. PubMed ID: 15164988
[TBL] [Abstract][Full Text] [Related]
2. Ototoxicity of carboplatin delivered locally in a monkey brainstem.
Carey JP; Cooper T; Jallo GI; Carson BS; Guarnieri M
Int J Toxicol; 2005; 24(6):443-9. PubMed ID: 16393937
[TBL] [Abstract][Full Text] [Related]
3. A surgical technique for safely placing a drug delivery catheter into the pons of primates: preliminary results of carboplatin infusion.
Storm PB; Clatterbuck RE; Liu YJ; Johnson RM; Gillis EM; Guarnieri M; Carson BS
Neurosurgery; 2003 May; 52(5):1169-76; discussion 1176-7. PubMed ID: 12699562
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of carboplatin brainstem infusions on hearing thresholds in monkeys.
May BJ; Guarnieri M; Carson BS; Bachani A; Jallo GI
Arch Otolaryngol Head Neck Surg; 2004 Dec; 130(12):1411-5. PubMed ID: 15611401
[TBL] [Abstract][Full Text] [Related]
5. Plasma and cerebrospinal fluid pharmacokinetics of intravenous oxaliplatin, cisplatin, and carboplatin in nonhuman primates.
Jacobs SS; Fox E; Dennie C; Morgan LB; McCully CL; Balis FM
Clin Cancer Res; 2005 Feb; 11(4):1669-74. PubMed ID: 15746072
[TBL] [Abstract][Full Text] [Related]
6. New approach to tumor therapy for inoperable areas of the brain: chronic intraparenchymal drug delivery.
Carson BS; Wu Q; Tyler B; Sukay L; Raychaudhuri R; DiMeco F; Clatterbuck RE; Olivi A; Guarnieri M
J Neurooncol; 2002 Nov; 60(2):151-8. PubMed ID: 12635662
[TBL] [Abstract][Full Text] [Related]
7. Direct delivery of platinum-based antineoplastics to the central nervous system: a toxicity and ultrastructural study.
Olivi A; Gilbert M; Duncan KL; Corden B; Lenartz D; Brem H
Cancer Chemother Pharmacol; 1993; 31(6):449-54. PubMed ID: 8453683
[TBL] [Abstract][Full Text] [Related]
8. Toxicity and toxicokinetics of the cyclin-dependent kinase inhibitor AG-024322 in cynomolgus monkeys following intravenous infusion.
Brown AP; Courtney CL; Criswell KA; Holliman CL; Evering W; Jessen BA
Cancer Chemother Pharmacol; 2008 Nov; 62(6):1091-101. PubMed ID: 18509643
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and toxicity of subcutaneous administration of carboplatin in poloxamer 407 in a rodent model pilot study.
Risselada M; Linder KE; Griffith E; Roberts BV; Davidson G; Zamboni WC; Messenger KM
PLoS One; 2017; 12(10):e0186018. PubMed ID: 28982137
[TBL] [Abstract][Full Text] [Related]
10. The formation and persistence of carboplatin-DNA adducts in rats.
Blommaert FA; Michael C; van Dijk-Knijnenburg HC; Schornagel JH; den Engelse L; Fichtinger-Schepman AM
Cancer Chemother Pharmacol; 1996; 38(3):273-80. PubMed ID: 8646803
[TBL] [Abstract][Full Text] [Related]
11. Interstitial delivery of carboplatin via biodegradable polymers is effective against experimental glioma in the rat.
Olivi A; Ewend MG; Utsuki T; Tyler B; Domb AJ; Brat DJ; Brem H
Cancer Chemother Pharmacol; 1996; 39(1-2):90-6. PubMed ID: 8995504
[TBL] [Abstract][Full Text] [Related]
12. Toxicity of high-dose carboplatin: ultrafiltered and not total plasma pharmacokinetics is of clinical relevance.
Kloft C; Siegert W; Beyer J; Jaehde U
J Clin Pharmacol; 2002 Jul; 42(7):762-73. PubMed ID: 12092743
[TBL] [Abstract][Full Text] [Related]
13. Continuous infusion of carboplatin during conventional radiotherapy treatment in advanced squamous carcinoma of the cervix uteri IIB-IIIB (UICC). A phase I/II and pharmacokinetic study.
Micheletti E; La Face B; Bianchi E; Cagna E; Apostoli P; Ruggeri G; Verardi R; Sartori E
Am J Clin Oncol; 1997 Dec; 20(6):613-20. PubMed ID: 9391552
[TBL] [Abstract][Full Text] [Related]
14. Carboplatin sustained delivery system using injectable microspheres.
Manunta ML; Gavini E; Chessa G; Passino ES; Careddu GM; Giua S; Mollica A; Demontis MP; Leoni A; Muzzetto P
J Vet Med A Physiol Pathol Clin Med; 2005 Oct; 52(8):416-22. PubMed ID: 16176573
[TBL] [Abstract][Full Text] [Related]
15. A Bayesian dosing method for carboplatin given by continuous infusion for 120 h.
Guillet P; Monjanel S; Nicoara A; Duffaud F; Lacarelle B; Bagarry-Liegey D; Durand A; Catalin J; Favre R
Cancer Chemother Pharmacol; 1997; 40(2):143-9. PubMed ID: 9182836
[TBL] [Abstract][Full Text] [Related]
16. Intra-arterial administration of carboplatin and the blood brain barrier permeabilizing agent, RMP-7: a toxicologic evaluation in swine.
Riley MG; Kim NN; Watson VE; Gobin YP; LeBel CP; Black KL; Bartus RT
J Neurooncol; 1998 Jan; 36(2):167-78. PubMed ID: 9525816
[TBL] [Abstract][Full Text] [Related]
17. Comparative intravenous toxicity of cisplatin solution and cisplatin encapsulated in long-circulating, pegylated liposomes in cynomolgus monkeys.
Working PK; Newman MS; Sullivan T; Brunner M; Podell M; Sahenk Z; Turner N
Toxicol Sci; 1998 Nov; 46(1):155-65. PubMed ID: 9928679
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of pelvic transarterial chemoembolization with lipiodol ultra-fluid carboplatin and transarterial carboplatin through experiment in dogs].
Chen CL; Sun MH; Tan DC; Liang LZ
Ai Zheng; 2004 Nov; 23(11 Suppl):1405-8. PubMed ID: 15566645
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid pharmacokinetics and toxicology of intraventricular and intrathecal arabinosyl-5-azacytosine (fazarabine, NSC 281272) in the nonhuman primate.
Heideman RL; McCully C; Balis FM; Poplack DG
Invest New Drugs; 1993; 11(2-3):135-40. PubMed ID: 7505267
[TBL] [Abstract][Full Text] [Related]
20. Hematologic and systemic toxicoses associated with carboplatin administration in cats.
Hahn KA; McEntee MF; Daniel GB; Legendre AM; Nolan ML
Am J Vet Res; 1997 Jun; 58(6):677-9. PubMed ID: 9185979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
